MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest income
$56,426
Change in fair value of
warrant liability
-$12,859
Net loss
-$1,781,255
Total other income
(expense)
$62,984
Interest expense
$6,301
Loss from operations
-$1,844,239
Total operating
expenses
$1,844,239
General and
administrative expenses
$1,224,546
Research and development
expenses
$619,693
Back
Back
Income Statement
source: myfinsight.com
Apimeds Pharmaceuticals US, Inc. (APUS)
Apimeds Pharmaceuticals US, Inc. (APUS)